Risk for COVID-19 breakthrough infection increased for cancer patients
A recent study published in JAMA Oncology has shown that [...]
ASCO GU 2023: Adjuvant pembrolizumab for different risks and stages of kidney cancer
At the American Society of Clinical Oncology Genitourinary Cancers Symposium [...]
ASCO 2021: Baseline characteristics affect survival with nivolumab plus cabozantinib
Ongoing results from the phase 3 CheckMate-9ER clinical trial with [...]
New risk scoring system for metastatic kidney cancer
The treatment options for metastatic renal cell carcinoma (RCC) have [...]
Selecting therapy for poor-risk advanced kidney cancer
In this video interview, Dr Earle Burgess from the Levine [...]
Real-world clinical outcomes with first-line sunitinib for metastatic kidney cancer
A paper published in The Oncologist last month analysed real-world [...]
Regular exercise reduces risk for 7 different cancers
A new study published in Journal of Clinical Oncology suggests [...]
Being overweight before the age of 40 increases cancer risk
A recent international study, lead by the University of Bergen [...]
Higher vitamin D levels associated with lower likelihood of kidney cancer
A new study, published in the International Brazilian Journal of [...]
Incidence of some obesity-related cancers in increasing in younger people
A recent study, published in The Lancet Public Health, has [...]
